Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sick And Tired Of Resiquimod? Then You Should Look At This

Individuals with missing outcome data were conservatively coded as not surviving to discharge, which may have biased the results toward the null. A strength of this study was the use of an Utstein-style data collection template and limited changes in OOHCA protocols during the study period. Future research should be conducted to determine if these findings are applicable to other EMS systems. Results from these analyses suggest that there is a negative association between prehospital endotracheal intubation attempts and survival Resiquimod from out-of-hospital cardiac arrest. In this study, the individuals most likely to have prehospital return of spontaneous circulation and survival to hospital discharge were those who did not have a reported endotracheal intubation attempt. Individuals experiencing out-of-hospital cardiac arrest may be another subset of prehospital patients who experience increased mortality when receiving prehospital endotracheal intubation. Further research should be conducted to better determine the effect endotracheal intubation has on prehospital patients. The authors would like to thank Deanna Vandeventer and Michelle Correll for their tireless efforts in help with data acquisition and Jason McMullan, MD for assisting in manuscript editing. Finally, we thank the EMS professionals at Mecklenburg selleck compound EMS Agency for their dedication and cooperation in supporting prehospital research. ""Rattlesnake envenomations commonly produce coagulopathy and thrombocytopenia, yet clinically significant bleeding is uncommon. It is unknown if patients who use antiplatelet or anticoagulant medications selleck kinase inhibitor prior to envenomation are at increased risk for bleeding after envenomation. This was a retrospective cohort study of patients age 14?years and older who were admitted to a single academic medical center for rattlesnake envenomation. Patients who reported use of antiplatelet or anticoagulant medications prior to envenomation were compared to patients not on those medications. Severity and timing of bleeding was compared between groups, as was a composite endpoint of major bleeding at any time, shock, readmission, or death. A total of 319 patients met inclusion criteria; 31 (9.7%) were documented to be taking antiplatelet or anticoagulant medications including aspirin, clopidogrel, and/or warfarin. Seventeen of the 319 patients developed bleeding associated with envenomation (major?=?9; minor?=?4; trivial?=?4), with major bleeding occurring in five patients on antiplatelet or anticoagulant medications versus four patients not on antiplatelet or anticoagulant medications (p?<?0.001). Seven of the 17 presented with early bleeding. This early bleeding occurred in three of 31 (9.7%) patients on antiplatelet or anticoagulant medications and four of 288 (1.4%) patients not on antiplatelet or anticoagulant medications (relative risk [RR]?= 6.9; 95% confidence interval [CI]?=?1.6 to 29.4; p?=?0.022).</div>
Sign In or Register to comment.